KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis

다국어 초록 (Multilingual Abstract)

Angiogenesis is considered to be an integral process to the growth and spread of solid tumors. Anti-angio-genesis therapy recently has been found to be one of the most promising anti-cancer therapeutic strategies. In this study, we provide several lines of evidences showing that KR-31831, a new ben-zopyran derivative, has anti-angiogenic activities. KR-31831 inhibited the proliferation, migration, invasion and tube formation of bovine aortic endothelial cells (BAECs), and suppressed the release of matrix metalloproteinase-2 (MMP-2) of BAECs. KR-31831 also inhibited in vivo angiogene-sis in mouse Matrigel plug assay. Furthermore, the mRNA expressions of basic fibroblast growth factor (bFGF), fibroblast growth factor receptor-2 (FGFR-2), and vascular endothelial growth factor receptor-2 (VEGFR-2) were decreased by KR-31831. Taken together, these results suggest that KR-31831 acts as a novel angiogenesis inhibitor and might be useful for treating hypervascularized cancers.

참고문헌 (Reference)

1 "of blood vesel formation" 22 : 251-256, 1997

2 "What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst" 4-6, 1990

3 "The implications of angiogenesis for the biology and therapy of cancer metastasis" 1994

4 "Spectrophotomeric constans for common hemoglobin derivaties in human" 1932

5 "Preclinical development of metal-loproteasis inhibitors in cancer therapy" 37 : 53-60, 2001

6 "Molecular mechanisms" 38 (38): 502-508, 2006

7 "Kallistatin is a new inhibitor of angiogenesis and tumor growth" 100 : 3245-3252, 2002

8 "Identification of a novel aniangiogenic agent; 4-(N-imidazol-2-ylmethyl)amino benzopyran analogues" 13 : 1661-1663, 2003

9 "Differential involvement of the hyaluronan receptors CD44 and receptor for HA-mediated motility in endothelial cell function"

10 "Clinical translation of angiogenesis inhibitors" 2 : 727-739, 2002

11 "Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models" 61 : 3290-3293, 2001

12 "Angiogenesis: regulators and clinical applications" 61 : 253-270, 2001

13 "Angiogenesis in vitro" 551-6, 1980

14 "Angiogenesis in cancer and other diseases" 407 : 249-257, 2000

15 "Angiogenesis and lung cancer: prognostic and therapeutic implications" 23 : 3243-3256, 2005

16 "A simple, quantitative method for assessing antiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor" 519-28, 1992